Related Experiment Videos
Improved control in diabetes with continuous subcutaneous insulin infusion
Diabetes Care
|November 1, 1980
Summary
Continuous subcutaneous insulin infusion improved glycemic control and well-being in diabetic patients. While not achieving absolute normalization, this method offers a promising approach for managing diabetes mellitus.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Diabetes Mellitus Management
Background:
- Insulin-dependent diabetes mellitus requires effective glycemic control to prevent complications.
- Continuous subcutaneous insulin infusion (CSII) is an advanced therapeutic option.
Purpose of the Study:
- To evaluate the efficacy of CSII in improving metabolic control and well-being in patients with insulin-dependent diabetes.
- To assess hormonal secretory patterns during CSII therapy.
Main Methods:
- Nine patients with insulin-dependent diabetes underwent CSII using portable infusion pumps.
- In-hospital acute study (4 days) followed by ambulatory treatment (up to 150 days).
- Home monitoring of capillary blood glucose and assessment of growth hormone and cortisol levels.
Main Results:
- Significant improvements observed in mean plasma glucose, M values, and glycosylated hemoglobin A1 (HbA1).
- Patients reported a significant enhancement in their sense of well-being.
- No significant alterations in growth hormone and cortisol secretory patterns were detected.
Conclusions:
- CSII therapy leads to significant improvements in glycemic control and patient well-being in insulin-dependent diabetes.
- Absolute normalization of blood glucose was not consistently achieved, with minor fluctuations observed.
- Further research is needed to compare CSII with multiple daily injections and to determine its long-term impact on diabetic complications.